Tobacco-related tumours of the lung, bladder and larynx: Changes in Spain

Annals of Oncology

Volumn 21, Issue SUPPL.3, 2010, Pages

  Izarzugaza, M I ^a   Ardanaz, E ^b,g   Chirlaque, M D ^c,g   Font, C ^d   Ameijide, A ^e   Linares, C ^f,g   Larranaga N ^h   Martinez C ⁱ   Sanchez S C ^j   Mateos, A ^k   Garcia J ^k   Martos, C ^l   Villardell, L ^m  

^a Basque Country Regional Authority   (Spain)

^b INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^c Health Authority   (Spain)

^d Mallorca Cancer Registry   (Spain)

^e INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^f CARLOS III INSTITUTE OF HEALTH   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h Basque Country Regional Authority   (Spain)

ⁱ ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^j Health and Medical Services Authority   (Spain)

^k Health and Social Welfare Authority   (Spain)

^l INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^m DEPARTMENT OF HEALTH   (Spain)

more..

Author keywords

Bladder; Cancer; Larynx; Lung; Spain; Tobacco

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SPAIN; TREND STUDY; AGE; BLADDER TUMOR; COMPARATIVE STUDY; LARYNX TUMOR; LUNG TUMOR; TOBACCO DEPENDENCE;

ADULT; AGE FACTORS; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; SEX FACTORS; SMOKING; SPAIN; TOBACCO USE DISORDER; URINARY BLADDER NEOPLASMS;

EID: 79951797936     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq084     Document Type: Article

References (38)

1. Doll R, Hill AB. A study of the aetiology of carcinoma of the lung. BMJ 1952; 2: 1271-1286.
2. Boyle P, Levin B. (eds): World Cancer Report 2008: Tobacco Smoking. Lyon, France: IARC 2008.
3. Baron JA, Rohan TE. Tobacco. In Schottenfeld D, Fraumeni JF Jr. (eds): Cancer Epidemiology and Prevention, 2nd edition. New York: Oxford University Press 1996; 269-289.
4. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2004; 45 (Suppl 2): S3-S9.
5. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoking. Vol. 38. Lyon, France: IARC 1986.
6. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking. Vol. 83. Lyon, France: IARC 2004.
7. World Health Organization Tobacco Free Initiative. Tobacco facts Available at: http://www.who.int/tobacco/mpower/tobacco_facts/en/index.html (August 2009, date last accessed).
8. WHO Regional Office for Europe. The European Tobacco Control Report 2007. Copenhagen, Denmark: World Health Organization 2007.
9. Regidor E, Gutiérrez-Fisac JL, Ichaso MS, Fernández E. Trends in principal cancer risk factors in Spain. Ann Oncol 2010; 21 (Suppl 3): iii43-iii51.
10. Ley de medidas sanitarias frente al tabaquismo y reguladora de la venta, el suministro y la publicidad de los productos del tabaco. Ley N° 28/2005 (27 diciembre de 2005). Available at: http://www.boe.es/boe/dias/2005/12/27/pdfs/A42241-42250.pdf (August 2009 date accessed).
11. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
12. Curado MP, Edwards B, Shin HR et al. (eds): Cancer Incidence in Five Continents. (IARC Scientific Publication No 160). Lyon, France: IARC 2008.
13. Mortalidad por cáncer, por enfermedad isquémica del corazón, por enfermedades cerebrovasculares y por diabetes mellitus en Españ a. Madrid: Ministerio de Sanidad y Consumo.
14. La situación del cáncer en Españ a. Ministerio de Sanidad y Consumo. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Área de Epidemiología Ambiental y Cáncer. Madrid, Spain: Centro de Publicaciones 2005.
15. Pastor-Barriuso R, Guallar E, Coresh J. Transition models for change-point estimation in logistic regression. Stat Med 2003; 22: 1141-1162.
16. Fritz A, Percy C, Jack A et al. (eds): Clasificación Internacional de Enfermedades para Oncología, 3a edición. Washington, DC: Organización Panamericana de la Salud 2003.
17. McCullagh P, Nelder JA. Generalized Linear Models, 2nd edition. London, UK: Chapman & Hall 1989.
18. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
19. Doll R, Peto R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50 years' observations on British doctors. Br J Cancer 2005; 92: 426-429.
20. Fernández E, Schiaffino A, García M et al. Prevalencia del consumo de tabaco en Españ a entre 1945 y 1995. Reconstrucción a partir de las Encuestas Nacionales de Salud. Med Clin (Barc) 2003; 120: 14-16.
21. Engeland A, Haldorsen T, Andersen A, Tretli S. The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 366-376.
22. Kreuzer M, Boffeta P, Whitely E et al. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer 2000; 82: 227-233.
23. Gandini S, Botteri E, Iodice S et al. Tobacco smoking and cancer: a metaanalysis. Int J Cancer 2008; 122: 155-164.
24. Agudo A, Ahrens W, Benhamou E et al. Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. Int J Cancer 2000; 88: 820-827.
25. López-Abente G, Pollán M, de la Iglesia P, Ruiz M. Characterization of the lung epidemic in the European Union 1970-1990. Cancer Epidemiol Biomarkers Prev 1995; 4: 813-820.
26. Zatonski WA, Manczuck M, Powels J, Negri E. Convergence of male and female lung cancer mortality at younger ages in the European Union and Russia. Eur J Pub Health 2007; 17: 450-454.
27. Vineis P, Hoek G, Krzyzanowski M et al. Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ Health 2007; 6: 7.
28. González CA, López-Abente G, Errezola M et al. Occupation and bladder cancer in Spain: a multicentre case-control study. Int J Epidemiol 1989; 18: 569-577.
29. Hashibe M, Brennan P, Benhamou S et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777-789.
30. Smith A, Handley MA, Word R. Epidemiological evidence indicates asbestos causes laryngeal cancer. J Occup Med 1990; 32: 499-507.
31. Garcia-Perez J, Pollan M, Boldo E et al. Mortality due to lung, laryngeal and bladder cancer in towns lying in the vicinity of combustion installations. Sci Total Environ 2009; 407: 2593-2602.
32. Pérez-Ríos M, Leistikow B, Montes A. El cáncer de pulmón como marcador del tabaquismo: relación con la mortalidad por cáncer no pulmonar. Gac Sanit 2009 23, 3: 224-227.
33. Devesa SS, Bray F, Vizcaino P, Parkin DM. International lung cancer trends by histologic type: male-female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 294-299.
34. Govindan R, Page N, Morgensztern D et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic and end results database. J Clin Oncol 2006; 24: 4539-4544.
35. Izarzugaza I. El cáncer de pulmón en Españ a. Revisión epidemiológica. Arch Bronconeumol 1992; 28: 311-319.
36. Ferlay J, Randi G, Bosetti C et al. Declining mortality from bladder cancer in Europe. Urol Oncol 2007; 101: 11-19.
37. Galán I, López MJ. Tres añ os con 'Ley de medidas sanitarias frente al tabaquismo': aire mas limpio, pero no lo suficiente. Gac Sanit 2009; 23: 87-90.
38. Hormigo J, García-Altés A, López MJ et al. Análisis de coste-beneficio de un programa de prevención del tabaquismo en escolares. Gac Sanit 2009; 23: 331-314.